• SENSEX 81,911.01
    31.61 (+0.04%)
  • BANKNIFTY 61,518.50
    726.10 (+1.19%)
Back

Corporate News

Gland Pharma appoints Xiao Le as CIO for international investment and M&A efforts
09-Nov-2026, 10:36

Gland Pharma Limited announced the appointment of Mr. Xiao Le as Chief Investment Officer of its wholly-owned subsidiary, Gland Pharma International Pte. Ltd. (‘Gland Singapore’), effective November 9, 2026, with Mr. Le responsible for exploring investment opportunities and improving merger and acquisition capabilities for Gland in the United States, China, Singapore, and other countries, reporting to the CEO of Gland Singapore.